ClinConnect ClinConnect Logo
Search / Trial NCT06505148

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

Launched by BAYLOR RESEARCH INSTITUTE · Jul 15, 2024

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Non Opioid Pain Management Pediatric Pain Pediatric Pain Management

ClinConnect Summary

This clinical trial is looking at how well different pain relief methods work for children who have had general surgery, such as hernia repairs or appendectomies. Researchers want to find out if alternating doses of acetaminophen and ibuprofen every three hours is better for managing pain compared to giving both medications together around the clock.

To participate in this trial, children aged 3 to 18 who are scheduled for certain types of surgeries at McLane Children's Hospital may be eligible. However, children with allergies to acetaminophen or ibuprofen, or those who are being evaluated for non-accidental trauma, will not be able to join. If eligible, participants will receive either the alternating or combined treatment and will be closely monitored for pain relief and any side effects. This study aims to improve how we manage pain in young patients after surgery, helping them feel better faster.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age group: 3 years to 18 years
  • General surgery service (hernia, appendectomy, chole, circumcision, wounds, vacs, implanted central line, etc.)
  • Exclusion Criteria:
  • Patients who are allergic to acetaminophen and/or ibuprofen
  • Patients being evaluated by SANE or evaluated for nonaccidental trauma
  • Patients admitted post-op
  • The study will take place at McLane Children's Hospital Temple Market. Patients who are pregnant.

About Baylor Research Institute

Baylor Research Institute (BRI) is a leading clinical research organization affiliated with Baylor Scott & White Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on translational medicine, BRI conducts a wide range of clinical trials across various therapeutic areas, including cardiovascular, oncology, and neurology. The institute is committed to fostering collaborative partnerships with academic institutions, industry leaders, and healthcare professionals to enhance the development of novel therapies and interventions. Through rigorous scientific methodology and ethical standards, Baylor Research Institute strives to contribute significantly to the advancement of healthcare and to provide patients with access to cutting-edge treatments.

Locations

Temple, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported